Vaxcyte, Inc. Income Statement

Income Statement Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue -0.07M-0.04M-0.01M-0.01M0.41M2.87M-4.38M
Gross Profit -0.07M-0.04M-0.01M-0.01M0.41M2.87M-4.38M
Operating items
Research & Development 30.14M45.61M73.56M78.41M169.45M332.34M476.64M
Selling, General & Administrative 5.39M8.55M16.02M25.26M39.81M60.70M92.90M
Other Operating Expenses 23.00M75.00M
Operating Expenses 35.53M54.15M89.58M103.67M232.26M468.04M569.55M
Operating Income -35.53M-54.15M-89.58M-103.67M-232.26M-468.04M-569.55M
EBIT -35.53M-54.15M-89.58M-103.67M-232.26M-468.04M-569.55M
Non-operating items
Interest & Investment Income 0.90M0.63M0.24M0.34M8.36M62.91M109.99M
Other Non Operating Income 6.05M3.88M-2.35M3.59M8.77M65.78M105.62M
Non Operating Income 6.05M3.88M0.36M3.59M8.77M65.78M105.62M
Net income details
EBT -34.70M-53.56M-89.34M-103.33M-223.90M-405.13M-459.55M
Profit After Tax -29.48M-50.27M-89.22M-100.08M-223.49M-402.27M-463.93M
Income from Continuing Operations -34.70M-53.56M-89.34M-103.33M-223.90M-405.13M-459.55M
Consolidated Net Income -34.70M-53.56M-89.34M-103.33M-223.90M-405.13M-459.55M
Income towards Parent Company -34.70M-53.56M-89.34M-103.33M-223.90M-405.13M-459.55M
Net Income towards Common Stockholders -29.48M-50.27M-89.22M-100.08M-223.49M-402.27M-459.55M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 46.76M50.95M52.79M78.98M95.15M124.64M
EBITDA -35.53M-54.15M-89.58M-103.67M-232.26M-468.04M-569.55M